Project Details
| Short title | 1479-0009 |
|---|---|
| Acronym | Beamion PANTUMOR-1 |
| Status | Active |
| Effective start/end date | 18/09/24 → 12/08/29 |
CTU: Beamion PANTUMOR-1: A Phase II, multicentre, multicohort, open-label trial to evaluate the efficacy and safety of oral zongertinib (BI 1810631) for the treatment of selected HER2-mutated or overexpressed/amplified solid tumours
- Park, John (Primary Chief Investigator)
- Martin, Lewis (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- McHugh, Tracey (Clinical Trial Unit Staff)
Project: Research